Gilead and LEO Pharma partner to develop oral STAT6 program - PharmaTimes Companies aim to provide new treatments for inflammatory conditions

#GileadSciences #LEOPharma #strategicpartnership #drugdevelopment #atopicdermatitis #asthma #COPD #dermatology #skindiseases #respiratory #smallmoleculeinhibitors #targetedproteindegraders #STAT6pathway #oralSTAT6products #topicalSTAT6products
pharmatimes.com/uncategorize...